Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$65,949
-$3,736 QoQ
Shares Held
522
+4.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,034
of 2,266 holders
Holding Since
Jun 2021
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kemnay Advisory Services Inc. holds $947,865 across 8 Drug Manufacturers - General names. GILD ranks #5 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
303 | $363,427 | |
| 2 | ABBV |
AbbVie Inc.
|
721 | $181,432 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,043 | $134,025 | |
| 4 | AMGN |
Amgen Inc
|
228 | $82,563 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
522 | $65,949 | |
| 6 | PFE |
Pfizer Inc
|
2,384 | $57,406 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
862 | $49,668 | |
| 8 | BIIB |
Biogen Inc.
|
62 | $13,395 |
All Filings in GILD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,949 | 522 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $69,685 | 500 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $60,633 | 494 | Shares | Sole | 2026-02-17 | |
| 2021-06-30 | $803,527 | 11,669 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||